Concepedia

Caitlin O’Toole

CO

1

Publications

15

Citations

1

H-Index

2023

Active since

Affiliations

Xilio Therapeutics (United States)(Current)

Caitlin O’Toole is an author at Xilio Therapeutics (United States).

ORCID

Publications per year

2023–2023

1

Publications

1

XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer

Kurt A. Jenkins, Miso Park, Magali Pederzoli-Ribeil et al. · Journal for ImmunoTherapy of Cancer · 2023 · 15 citations · Full text

Rows per page

1–1 of 1